Literature DB >> 32389335

Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.

Doreen M Rabi1, Kerry A McBrien2, Ruth Sapir-Pichhadze3, Meranda Nakhla4, Sofia B Ahmed5, Sandra M Dumanski5, Sonia Butalia6, Alexander A Leung7, Kevin C Harris8, Lyne Cloutier9, Kelly B Zarnke10, Marcel Ruzicka11, Swapnil Hiremath12, Ross D Feldman13, Sheldon W Tobe14, Tavis S Campbell15, Simon L Bacon16, Kara A Nerenberg17, George K Dresser18, Anne Fournier19, Ellen Burgess20, Patrice Lindsay21, Simon W Rabkin22, Ally P H Prebtani23, Steven Grover24, George Honos25, Jeffrey E Alfonsi18, JoAnne Arcand26, François Audibert27, Geneviève Benoit28, Jesse Bittman29, Peter Bolli30, Anne-Marie Côté31, Janis Dionne32, Andrew Don-Wauchope33, Cedric Edwards11, Tabassum Firoz34, Jonathan Y Gabor35, Richard E Gilbert36, Jean C Grégoire37, Steven E Gryn18, Milan Gupta38, Fady Hannah-Shmouni39, Robert A Hegele18, Robert J Herman40, Michael D Hill41, Jonathan G Howlett42, Gregory L Hundemer11, Charlotte Jones43, Janusz Kaczorowski44, Nadia A Khan29, Laura M Kuyper29, Maxime Lamarre-Cliche45, Kim L Lavoie46, Lawrence A Leiter47, Richard Lewanczuk48, Alexander G Logan49, Laura A Magee50, Birinder K Mangat29, Philip A McFarlane51, Donna McLean52, Andre Michaud53, Alain Milot54, Gordon W Moe55, S Brian Penner56, Andrew Pipe57, Alexandre Y Poppe58, Evelyne Rey59, Michael Roerecke60, Ernesto L Schiffrin61, Peter Selby62, Mike Sharma63, Ashkan Shoamanesh64, Praveena Sivapalan65, Raymond R Townsend66, Karen Tran29, Luc Trudeau67, Ross T Tsuyuki68, Michel Vallée69, Vincent Woo70, Alan D Bell71, Stella S Daskalopoulou72.   

Abstract

Hypertension Canada's 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Canada develops the guidelines using rigourous methodology, carefully mitigating the risk of bias in our process. All draft recommendations undergo critical review by expert methodologists without conflict to ensure quality. Our guideline panel is diverse, including multiple health professional groups (nurses, pharmacy, academics, and physicians), and worked in concert with experts in primary care and implementation to ensure optimal usability. The 2020 guidelines include new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.
Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32389335     DOI: 10.1016/j.cjca.2020.02.086

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  70 in total

1.  Reply.

Authors:  Kaitlyn E Watson; Yazid N Al Hamarneh; Doreen Rabi; Stella S Daskalopoulou; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2021-04-19

2.  Factors Associated With Failure to Achieve the Intensive Blood Pressure Target in the Systolic Blood Pressure Intervention Trial (SPRINT).

Authors:  Katherine M Wang; Margaret R Stedman; Glenn M Chertow; Tara I Chang
Journal:  Hypertension       Date:  2020-11-02       Impact factor: 10.190

3.  Rapid recommendations: Updates from 2020 guidelines: part 1.

Authors:  Danielle O'Toole
Journal:  Can Fam Physician       Date:  2021-12       Impact factor: 3.275

Review 4.  Primary Aldosteronism: a Continuum from Normotension to Hypertension.

Authors:  Taweesak Wannachalee; Adina F Turcu
Journal:  Curr Cardiol Rep       Date:  2021-07-01       Impact factor: 2.931

5.  PASCAR commentary on the International Society of Hypertension global guidelines 2020: relevance to sub-Saharan Africa.

Authors:  E S Jones; Albertino Damasceno; Elijah N Ogola; Dike B Ojji; Anastase Dzudie; B L Rayner
Journal:  Cardiovasc J Afr       Date:  2020 Nov-Dec       Impact factor: 1.167

6.  Variation in hypertension clinical practice guidelines: a global comparison.

Authors:  Richu Philip; Thomas Beaney; Nick Appelbaum; Carmen Rodriguez Gonzalvez; Charlotte Koldeweij; Amelia Kataria Golestaneh; Neil Poulter; Jonathan M Clarke
Journal:  BMC Med       Date:  2021-05-12       Impact factor: 8.775

7.  Systematic review of international clinical guidelines for the promotion of physical activity for the primary prevention of cardiovascular diseases.

Authors:  N Aerts; D Le Goff; M Odorico; J Y Le Reste; P Van Bogaert; L Peremans; G Musinguzi; P Van Royen; H Bastiaens
Journal:  BMC Fam Pract       Date:  2021-05-19       Impact factor: 2.497

Review 8.  Guideline-Driven Management of Hypertension: An Evidence-Based Update.

Authors:  Robert M Carey; Jackson T Wright; Sandra J Taler; Paul K Whelton
Journal:  Circ Res       Date:  2021-04-01       Impact factor: 17.367

Review 9.  Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension.

Authors:  Bin Zhou; Pablo Perel; George A Mensah; Majid Ezzati
Journal:  Nat Rev Cardiol       Date:  2021-05-28       Impact factor: 32.419

10.  Review of Referrals Sent to the Emergency Department for Management of Hypertension.

Authors:  Andre Emmanuel Richard; Marie-Helene Chomienne
Journal:  Cardiol Res       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.